ADVENZYMES

Advanced Enzyme Technologies Limited

Specialty enzymes for human nutraceuticals, animal feed and bioprocessing

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Biotechnology

advancedenzymes.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹267.00
Market cap
2,992 Cr
Stock P/E
18.0
P/B
1.83
Dividend yield
2.0%
ROE (FY26)
10.0%
ROCE (FY26)
13.8%
Operating margin (FY26)
25.3%
Debt / equity (FY26)
0.01
OCF / EBITDA (FY26)
68.4%
OCF / EBITDA (3Y)
70.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Advanced Enzyme Technologies (Advanced Enzymes) manufactures enzymes and sells them to human health, animal nutrition and industrial bioprocessing customers in India and overseas.

Company snapshot

2ndBy market cap

Ranked among 2 companies in Biotechnology.

What we see

Positives
  • ✓Net margin of 23.3% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales158 Cr161 Cr158 Cr155 Cr146 Cr169 Cr167 Cr186 Cr185 Cr172 Cr203 Cr190 Cr
Operating expenses (approx.)107 Cr107 Cr102 Cr103 Cr104 Cr114 Cr122 Cr129 Cr124 Cr123 Cr140 Cr139 Cr
EBITDA51 Cr54 Cr55 Cr51 Cr42 Cr55 Cr46 Cr56 Cr60 Cr49 Cr63 Cr51 Cr
OPM %32.5%33.4%35.1%33.1%29.0%32.7%27.3%30.4%32.5%28.7%31.1%26.9%
Other income6 Cr14 Cr9 Cr7 Cr10 Cr8 Cr9 Cr9 Cr10 Cr8 Cr7 Cr13 Cr
Interest0.75 Cr0.68 Cr0.85 Cr0.87 Cr0.93 Cr0.94 Cr0.81 Cr0.76 Cr0.72 Cr0.57 Cr0.57 Cr0.58 Cr
Depreciation9 Cr9 Cr9 Cr9 Cr9 Cr9 Cr10 Cr10 Cr10 Cr10 Cr10 Cr10 Cr
Profit before tax48 Cr59 Cr40 Cr49 Cr42 Cr53 Cr43 Cr55 Cr60 Cr58 Cr60 Cr54 Cr
Tax %26.6%27.8%24.6%28.1%20.9%26.7%38.5%26.3%24.9%25.9%24.3%27.9%
Net profit35 Cr43 Cr30 Cr35 Cr33 Cr39 Cr27 Cr40 Cr45 Cr43 Cr45 Cr39 Cr
EPS (₹)₹3.08₹3.74₹2.53₹3.05₹2.94₹3.36₹2.37₹3.57₹3.87₹3.80₹3.84₹3.31

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales343 Cr396 Cr420 Cr444 Cr502 Cr529 Cr541 Cr624 Cr637 Cr746 CrSign in free for the trailing twelve months
Operating expenses (approx.)192 Cr232 Cr238 Cr242 Cr270 Cr328 Cr384 Cr419 Cr442 Cr517 CrSign in free for the trailing twelve months
EBITDA151 Cr164 Cr182 Cr202 Cr232 Cr201 Cr156 Cr204 Cr194 Cr229 CrSign in free for the trailing twelve months
OPM %44.0%41.4%43.4%45.6%46.1%38.0%28.9%32.8%30.5%30.7%Sign in free for the trailing twelve months
Other income3 Cr1 Cr5 Cr6 Cr9 Cr6 Cr25 Cr37 Cr33 Cr35 CrSign in free for the trailing twelve months
Interest4 Cr8 Cr4 Cr3 Cr2 Cr2 Cr2 Cr3 Cr4 Cr3 CrSign in free for the trailing twelve months
Depreciation13 Cr18 Cr21 Cr26 Cr28 Cr35 Cr35 Cr35 Cr37 Cr40 CrSign in free for the trailing twelve months
Profit before tax137 Cr139 Cr162 Cr179 Cr210 Cr171 Cr140 Cr188 Cr187 Cr233 CrSign in free for the trailing twelve months
Tax %32.2%32.7%28.4%25.7%28.0%27.6%26.0%27.1%28.5%25.3%Sign in free for the trailing twelve months
Net profit93 Cr94 Cr116 Cr133 Cr151 Cr124 Cr104 Cr137 Cr134 Cr174 CrSign in free for the trailing twelve months
EPS (₹)₹8.27₹8.07₹9.95₹11.58₹13.09₹10.70₹9.45₹11.92₹11.72₹15.08Sign in free for the trailing twelve months
Dividend payout %————5.3%0.0%12.1%41.4%44.1%34.4%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr22 Cr
Reserves442 Cr537 Cr657 Cr817 Cr948 Cr1,066 Cr1,213 Cr1,302 Cr1,398 Cr1,610 Cr
Borrowings46 Cr58 Cr28 Cr17 Cr15 Cr11 Cr13 Cr25 Cr22 Cr21 Cr
Other liabilities58 Cr92 Cr78 Cr94 Cr107 Cr116 Cr124 Cr139 Cr131 Cr135 Cr
Total liabilities589 Cr732 Cr811 Cr979 Cr1,153 Cr1,268 Cr1,422 Cr1,535 Cr1,621 Cr1,839 Cr
Fixed assets (net)166 Cr167 Cr162 Cr210 Cr238 Cr262 Cr273 Cr277 Cr293 Cr276 Cr
CWIP1 Cr3 Cr5 Cr5 Cr5 Cr10 Cr16 Cr31 Cr22 Cr51 Cr
Investments0.07 Cr0.07 Cr111 Cr124 Cr121 Cr102 Cr360 Cr403 Cr480 Cr584 Cr
Loans & advances——0.13 Cr0.07 Cr0.09 Cr0.09 Cr0.12 Cr0.10 Cr0.10 Cr0.24 Cr
Inventories68 Cr76 Cr77 Cr80 Cr94 Cr121 Cr124 Cr148 Cr157 Cr177 Cr
Trade receivables50 Cr59 Cr59 Cr75 Cr86 Cr88 Cr100 Cr99 Cr115 Cr145 Cr
Cash & bank8 Cr61 Cr23 Cr83 Cr192 Cr267 Cr96 Cr114 Cr94 Cr109 Cr
Other assets295 Cr367 Cr375 Cr403 Cr416 Cr417 Cr452 Cr464 Cr459 Cr497 Cr
Total assets589 Cr732 Cr811 Cr979 Cr1,153 Cr1,268 Cr1,422 Cr1,535 Cr1,621 Cr1,839 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——129 Cr141 Cr163 Cr124 Cr140 Cr141 Cr142 Cr157 Cr
Cash from investing——-125 Cr-44 Cr-26 Cr-26 Cr-298 Cr-65 Cr-89 Cr-74 Cr
Cash from financing——-43 Cr-39 Cr-26 Cr-27 Cr-26 Cr-59 Cr-73 Cr-70 Cr
Net cash flow——-39 Cr58 Cr109 Cr75 Cr-171 Cr17 Cr-20 Cr15 Cr
Free cash flow (OCF − Capex)——116 Cr90 Cr143 Cr95 Cr102 Cr94 Cr108 Cr104 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %26.5%23.0%22.6%20.6%20.3%15.0%11.0%13.7%12.8%13.8%
ROE %18.9%16.1%15.8%14.9%14.2%10.5%8.2%9.7%8.9%10.0%
Debtor days53545161636168586671
Inventory days357344426322341338354349354332
Days payable57805439555069373975
Cash conversion cycle352318423345348349352369381328
OCF / EBITDA %——70.7%69.6%70.4%61.3%89.7%69.1%73.3%68.4%
OCF / EBITDA % (3 years)————70.2%67.3%72.4%72.1%76.4%70.2%
Debt / equity0.100.100.040.020.020.010.010.020.020.01
Current ratio2.242.134.336.317.6410.009.317.619.099.78
Net debt / EBITDA0.26—0.03-0.33-0.77-1.27-0.53-0.43-0.37-0.39